Clinical Trials
임상시험 트래커
국내사는 전체 임상 이력, 글로벌 메이저는 진행 중 파이프라인을 추적합니다. ClinicalTrials.gov API v2에서 6시간 주기로 수집합니다.
기업
60 results (top 60)
- 3상모집 중단 (진행 중)· Diphtheria-Tetanus-acellular Pertussis Vaccines일본 건강한 임산부에서 디프테리아·파상풍·무세포 백일해(dTpa) 복합백신의 면역반응 및 안전성 연구
A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTpa) in Japanese Healthy Pregnant Women
리드: GSK
- 1상모집 중단 (진행 중)· Pneumonia, BacterialTrial to Evaluate Safety and Immune Response of an Investigational Pneumococcal Vaccine in Adults Aged 50 To 64 Years
리드: GSK
- 3상모집 중단 (진행 중)· Respiratory Syncytial Virus InfectionsA Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus Given to Chinese Adults 18 to 59 Years of Age at Increased Risk of Respiratory Syncytial Virus Disease
리드: GSK
- 1상모집 중단 (진행 중)· Hepatitis BA Study to Evaluate Blood Levels of Bepirovirsen in Adult Participants With Severe or Moderate Kidney Disease
리드: GSK
- 2상모집 중단 (진행 중)· Respiratory Syncytial Virus InfectionsA Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine and the Safety and Immune Response Following Revaccination in Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant
리드: GSK
- 1/2상모집 중단 (진행 중)· MelanomaA Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
리드: GSK
- 1상모집 중단 (진행 중)· Colitis, UlcerativeA First-time in Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Target Engagement of GSK4528287 in Healthy Participants
리드: GSK
- 2상모집 중단 (진행 중)· Chronic Hepatitis B Virus InfectionA Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB)
리드: GSK
- 2상모집 중단 (진행 중)· Neoplasms, RectalA Study of Dostarlimab in Participants With Untreated Locally Advanced Rectal Cancer in China
리드: GSK
- 2상모집 중단 (진행 중)· Plasma Cell MyelomaBelantamab Mafodotin and Lenalidomide for the Treatment of Multiple Myeloma in Patients With Minimal Residual Disease Positive After Stem Cell Transplant
협력: GSK
- 3상모집 중단 (진행 중)· Respiratory Syncytial Virus InfectionsAn Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study
리드: GSK
- 3상모집 중단 (진행 중)· GlioblastomaA Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma
협력: GSK
- 4상모집 중단 (진행 중)· Systemic Lupus ErythematosusA Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)
리드: GSK
- 1/2상모집 중단 (진행 중)· Recurrent Vulvovaginal CandidiasisAssessing the Safety, Immune Response, and Early Efficacy of a Candida Vaccine in Women With Recurrent Vulvovaginal Candidiasis: A Randomized Controlled Study
협력: GSK
- 1상모집 중단 (진행 중)· Pulmonary Disease, Chronic ObstructiveA Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease
리드: GSK
- 1/2상모집 중단 (진행 중)· Head and Neck Squamous Cell CarcinomaTwo-cohort Study of Niraparib and Dostarlimab Plus (Chemo)RadIotherapy in Locally-Advanced Head and Neck Squamous Cell Carcinoma
협력: GSK
- 4상모집 중단 (진행 중)· Meningitis, MeningococcalA Study on the Immune Response and Safety of a Vaccine Against N. Meningitidis Serogroup B Infection in Healthy Infants From 2 Months of Age
리드: GSK
- 단계 미표기모집 중단 (진행 중)· Ovarian CancerA Collaborative Trial of Niraparib to Evaluate Patients With Ovarian Cancer in the Expanded Access Program in Latin America
협력: GSK
- 단계 미표기모집 중단 (진행 중)· Respiratory Syncytial Virus (RSV)Effect of Respiratory Virus Infection on EmeRgencY Admission Study (EVERY Study)
협력: GSK
- 4상모집 중단 (진행 중)· Rheumatoid ArthritisRecombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases
협력: GSK
- 단계 미표기모집 중단 (진행 중)· Severe AsthmaUsing NLP and Neural Networks to Autonomously Identify Severe Asthma and Determine Study Eligibility in a Large Healthcare System
협력: GSK
- 2상모집 중단 (진행 중)· Neoplasms, RectalA Study of Dostarlimab in Untreated dMMR/MSI-H Locally Advanced Rectal Cancer
리드: GSK
- 4상모집 중단 (진행 중)· AsthmaSymptoms Control and adhErenCe Assessment During Treatment With MepolizUmab New pREfilled Devices
협력: GSK
- 단계 미표기모집 중단 (진행 중)· Multiple Myeloma in RelapseImpact of a Health Technology Intervention on Patient Activation in Multiple Myeloma
협력: GSK
- 2상모집 중단 (진행 중)· Nonalcoholic Fatty Liver DiseasePhase 2b Study of GSK4532990 in Adults With NASH
리드: GSK
- 2상모집 중단 (진행 중)· Lung Cancer, Non-Small CellA Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/Metastatic Non-Small-Cell Lung Cancer
리드: GSK
- 2상모집 중단 (진행 중)· Sarcoma,Soft TissueA Study of Niraparib in People With Soft Tissue Sarcoma Who Have Changes in Their Tumor DNA
협력: GSK
- 3상모집 중단 (진행 중)· Herpes ZosterA Study on the Long-term Efficacy, Safety and Persistence of Immune Response of a Vaccine Against Herpes Zoster in Older Adults
리드: GSK
- 3상모집 중단 (진행 중)· AsthmaEvaluation of Triple Therapy Using Magnetic Resonance Imaging in Asthma
협력: GSK
- 1/2상모집 중단 (진행 중)· Multiple MyelomaSub-study of Belantamab Mafodotin (GSK2857916) in Combination With Nirogacestat, Lenalidomide, and Dexamethasone in Participants With RRMM
리드: GSK
- 3상모집 중단 (진행 중)· Eosinophilic Granulomatosis With PolyangiitisEfficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)
리드: GSK
- 단계 미표기모집 중단 (진행 중)· Herpes ZosterSafety of Herpes Zoster Subunit (HZ/su) Vaccine During Pregnancy in Adult Women With Immunocompromised Conditions
리드: GSK
- 3상모집 중단 (진행 중)· Endometrial CancerEndometrial Cancer Patientes MMR Deficient Comparing Chemotherapy vs Dostarlimab in First Line
협력: GSK
- 1상모집 중단 (진행 중)· NeoplasmsFirst-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors
리드: GSK
- 1/2상모집 중단 (진행 중)· Multiple MyelomaNovel Combination of Belantamab Mafodotin and Elotuzumab to Enhance Therapeutic Efficacy in Multiple Myeloma
협력: GSK
- 2상모집 중단 (진행 중)· Chronic Lymphoid Leukemia in RelapseBelimumab in Patients with Chronic Lymphocytic Leukemia
협력: GSK
- 2상모집 중단 (진행 중)· Meningitis, MeningococcalSafety, Tolerability, and Immunogenicity of MenABCWY Administered on Different Dosing Schedules in Healthy Adolescents
리드: GSK
- 초기 1상모집 중단 (진행 중)· GlioblastomaTrial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma
협력: GSK
- 1상모집 중단 (진행 중)· Anatomic Stage III Breast Cancer AJCC v8Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer
협력: GSK
- 1/2상모집 중단 (진행 중)· Multiple MyelomaSub-study of Belantamab Mafodotin (GSK2857916) in Combination With Isatuximab in Participants With RRMM
리드: GSK
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.